Premium
No evidence of increased risk for Coronavirus Disease 2019 (COVID‐19) in patients treated with Dupilumab for atopic dermatitis in a high‐epidemic area – Bergamo, Lombardy, Italy
Author(s) -
Carugno A.,
Raponi F.,
Locatelli A.G.,
Vezzoli P.,
Gambini D.M.,
Di Mercurio M.,
Robustelli Test E.,
Sena P.
Publication year - 2020
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.16552
Subject(s) - atopic dermatitis , medicine , covid-19 , dermatology , family medicine , disease , infectious disease (medical specialty) , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom